Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom Macroglobulinemia
Clinical trial NCT01118689 · COMPLETED
Trial details
- NCT number
- NCT01118689
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2013-05-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.